Jeffrey W. Henderson
Independent DirectorMr. Jeffrey W. Henderson, also known as Jeff, serves as Independent Chair of the Board at Halozyme Therapeutics, Inc. He serves as a Partner at Tacoma Investment Holdings. He serves as the Director of the JQ Medical board. He serves as a Chair of the Board at Halozyme, Inc. He has been Independent Director of Becton, Dickinson and Company since August 16, 2018. Mr. Henderson is the President of JWH Consulting LLC since January 2018. He had been an Healthcare Advisory Director of Berkshire Partners LLC since September 2015 to January 2020. Mr. Henderson provides Halozyme Therapeutics, Inc. Board of Directors with a wealth of corporate leadership experience, particularly in corporate finance, having served as the Chief Financial Officer of Cardinal Health, Inc. from May 2005 to November 2014. Mr. Henderson has many years of financial, commercial and pharmaceutical industry experience. He served as an Executive Vice President of Cardinal Health, Inc since April 18, 2005. He served as an Interim Chief Executive Officer of Healthcare Supply Chain Services of Cardinal Health Inc., from November 5, 2007 to January 2008. He was deeply involved in a wide range of acquisitions and divestitures over his career at Cardinal. During his tenure, he had operational responsibility for various parts of the business. He served as President of Eli Lilly Canada. He served as General Manager of Canada at Eli Lilly Canada Inc. and Eli Lilly and Company from June 16, 2003 to April 2005. Mr. Henderson was Controller and Treasurer of Eli Lilly Inc. He served as Vice President and Corporate Controller of Eli Lilly & Co., from January 2000 to July 2003. Since 2003, Mr. Henderson served as Head of Lilly's Canadian unit. He joined Lilly in 1998 as Vice President and Corporate Treasurer, based at Cardinal Health Inc.'s headquarters in Indianapolis Ind. For many years, he held positions at General Motors Corp., including executive and managerial posts. He served as a Plant Supervisor and Electrical Engineer at General Motors in Canada in 1988. In 1991, Mr. Henderson moved to the General Motors Treasurer, where he served various positions involving finance. In 1994, he moved to establish the operation of the Regional Treasury Center and in 1996, assumed a senior role with General Motors' joint venture with Isuzu Motors. He has deep experience in pharmaceuticals, supply chain, distribution and the healthcare industry broadly. He serves as a Director of Canada's Research-Based Pharmaceutical Companies. He served as the Non-Executive Chairman of QUALCOMM Incorporated since March 2018 until August 13, 2019. Mr. Henderson has been a Director of Halozyme Therapeutics, Inc. since August 5, 2015. Mr. Henderson had been a Director of FibroGen, Inc. since August 6, 2015 until June 5, 2024. He serves as a Director of Integrated DNA Technologies, Inc. and serves as a trustee for the Columbus School for Girls. He has been an Independent Director at QUALCOMM Incorporated since January 12, 2016. He is a director of Affordable Care, Inc. Mr. Henderson has Master of Business Administration degree from Harvard Business School and a Bachelor of Science degree in Electrical Engineering from Kettering University.
Positions
- Company NameBecton, Dickinson and CompanyStock CodeBDXPositionIndependent DirectorColleagues
- TEThomas E. PolenPresident, CEO & Chairman
- MCMichael C. FeldExecutive VP & Chief Revenue Officer
- VRVitor RoqueExecutive VP & CFO
- EMElizabeth McCombsExecutive VP & CTO
- JMJoseph M. SmithSenior VP & Chief Scientific Officer
- CIChristopher Ian Montague JonesIndependent Director
- CMCatherine M. BurzikIndependent Director
- RARobert Andrew EckertLead Independent Director
- JWJeffrey W. HendersonIndependent Director
- Company NameHalozyme Therapeutics, Inc.Stock CodeHALOPositionIndependent Chair of the BoardColleagues
- HIHelen I. TorleyPresident, CEO & Director
- JWJeffrey W. HendersonIndependent Chair of the Board
- MSMark SnyderExecutive VP, General Counsel, Chief Compliance Officer & Corporate Secretary
- DSDarren SnellgroveSenior VP & CFO
- BSBrian SweeneyChief Human Resources Officer
- DADavid A. RamsayPresident of Drug Delivery
- GIGregory I. FrostChairman of Scientific Advisory Board
- MLMatthew L. PosardIndependent Director
- BMBernadette Mary ConnaughtonIndependent Director
- Company NameQUALCOMM IncorporatedStock CodeQCOMPositionIndependent DirectorColleagues
- CRCristiano Renno AmonCEO, President & Director
- MDMark D. McLaughlinIndependent Chairman of the Board
- APAkash PalkhiwalaExecutive VP, CFO & COO
- ANAnn N. Cathcart ChaplinExecutive VP, General Counsel & Corporate Secretary
- AHAlexander H. RogersExecutive VP, President of Qualcomm Technology Licensing (QTL) & Global Affairs
- BABaaziz AchourExecutive VP & Chief Technology Officer of Qualcomm Technologies, Inc.
- ESEnrico SalvatoriChairman of EMEA
- AMAnn M. LivermoreIndependent Director
